Sugentech Inc. (KOSDAQ:253840)
7,450.00
+480.00 (6.89%)
Aug 8, 2025, 3:30 PM KST
Sugentech Revenue
Sugentech had revenue of 1.89B KRW in the quarter ending March 31, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 10.03B, up 32.71% year-over-year. In the year 2024, Sugentech had annual revenue of 10.10B with 41.57% growth.
Revenue (ttm)
10.03B
Revenue Growth
+32.71%
P/S Ratio
11.36
Revenue / Employee
69.62M
Employees
144
Market Cap
113.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.10B | 2.96B | 41.57% |
Dec 31, 2023 | 7.13B | -94.27B | -92.97% |
Dec 31, 2022 | 101.40B | 24.20B | 31.34% |
Dec 31, 2021 | 77.20B | 35.85B | 86.69% |
Dec 31, 2020 | 41.35B | 37.51B | 975.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
SK Biopharmaceuticals | 578.00B |
Yuhan | 2,114.76B |
Peptron | 4.30B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |